Search results
Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
GuruFocus.com via Yahoo Finance· 3 hours agoThe company is still in the early stages of discussion with the FDA regarding the multi-dose expansion arm for their Phase 1 trial, indicating potential delays in trial progression ...
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...
GuruFocus.com via Yahoo Finance· 3 hours agoResearch and development expenses increased by $2.9 million due to higher licensing and clinical trial expenses, adding financial pressure as the company progresses towards ...
Column: No Mow May should be 'No Spray May': Let's stop abusing Mother Earth
The Palm Beach Post via Yahoo News· 59 minutes agoBut mowing isn’t the real issue; this month would be better called “No Spray May” as we need to stop...
WHO clears Takeda's dengue vaccine
Reuters via AOL· 1 day agoThe approval, called a prequalification, comes amidst a surge in mosquito-borne viral infections across Asia, Africa, and the Americas, including new...
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
GuruFocus.com via Yahoo Finance· 3 hours agoNet Loss (Q1 2024): $37.2 million, or $0.63 per share. Net Loss (Q4 2023): $9.1 million, or $0.15 per share. Cash and Investments (As of March 31, 2024) ...
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Investing.com· 11 hours agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...
Takeda’s dengue vaccine obtains WHO prequalification
Pharmaceutical Technology via Yahoo Finance· 1 hour agoIt is designed to be administered in a two-dose regimen with an interval of three months between doses. Sanofi Pasteur’s CYD-TDV dengue vaccine had...
From Boch, with love: Philanthropist provides life-saving donation to Salem family
The Salem News· 21 minutes ago“Over the years, we have achieved remarkable milestones,” an April announcement from the organization reads. “Together, we have raised $98 million, including $84 ...
BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
GuruFocus.com via Yahoo Finance· 23 hours agoExpected Operating Cash Burn: Approximately $20 million for Q2 2024, with a decrease anticipated in the second half of the year. Funding Operations: Current...and an 86% disease ...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 2 days agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...